ASM |
ISIN | NL0010273215 |
Security | ASM |
Exchange | EUREX |
Type | Option |
Options
Exp. date | Type | Type |
---|---|---|
2/21 | 33 Calls | 32 Puts |
3/21 | 33 Calls | 32 Puts |
4/21 | 9 Calls | 9 Puts |
6/21 | 27 Calls | 26 Puts |
9/21 | 15 Calls | 15 Puts |
12/21 | 23 Calls | 23 Puts |
6/22 | 15 Calls | 15 Puts |
12/22 | 16 Calls | 16 Puts |
6/23 | 11 Calls | 11 Puts |
12/23 | 16 Calls | 16 Puts |
12/24 | 14 Calls | 14 Puts |
12/25 | 8 Calls | 8 Puts |
Calls
Strike | Last | Open Interest | |
---|---|---|---|
320.00 | 55.50 | 2 | |
360.00 | 37.00 | 3 | |
400.00 | 24.10 | 1 | |
480.00 | 10.00 | 1 | |
500.00 | 24.80 | 1 | |
560.00 | 3.58 | 71 |
News
- T2 Biosystems Appoints Industry Expert Aparna Ahuja, MD as Chief Medical Officer
01/07/2021 / 14:00 - GlobeNewswire - ASML reports transactions under its current share buyback program
12/21/2020 / 14:00 - GlobeNewswire - Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections
12/17/2020 / 14:00 - GlobeNewswire - SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology
12/16/2020 / 14:00 - GlobeNewswire - Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
12/15/2020 / 14:00 - GlobeNewswire